This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Pharmacologic Characteristics of Ideal Antidepressants in the 21st Century

C. Lindsay DeVane, PharmD

Published: September 30, 2000

Article Abstract

The availability of drugs for use as antidepressants has expanded greatly in the past 2 decades. Not only has the number of drugs increased but so has the diversity in associated pharmacologic effects. Drug development for central nervous system agents is proceeding at an accelerated pace. The coming decades hold the promise for the introduction of newer antidepressants that have novel mechanisms of action, improved adverse event profiles, and expanded indications. Unfortunately, the ideal antidepressant is yet to be formulated. Pharmacologic characteristics for desirable improvements are discussed relative to the currently available drugs.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 2

Quick Links: Depression (MDD)

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Clinical and Practical Psychopharmacology

Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in...

Read More...